Literature DB >> 24242955

Regulated IRE1-dependent decay participates in curtailing immunoglobulin secretion from plasma cells.

Sandrine Benhamron1, Rivka Hadar, Takao Iwawaky, Jae-Seon So, Ann-Hwee Lee, Boaz Tirosh.   

Abstract

Inositol-requiring enzyme 1 (IRE1) is a kinase and ribonuclease that executes the splicing of X box binding protein 1 (XBP-1) mRNA in response to the accumulation of unfolded protein in the ER, a signal cascade termed the unfolded protein response. Recently, IRE1 has been implicated in mRNA and miRNA cleavage and degradation, a pathway termed regulated IRE1-dependent decay (RIDD). Deletion of XBP-1 in the liver and pancreas strongly enhances RIDD by upregulating IRE1 protein levels and enhancing its ribo-nuclease activity. Because XBP-1 is essential for generating plasma cells with developed secretory capacity, we sought to evaluate the contribution of RIDD to this regulation. Mice were conditionally deleted for XBP-1 and/or IRE1 in their B-cell lineage. Similarly to the liver, deletion of XBP-1 induces IRE1 expression in LPS-treated B cells. In vitro, IRE1 cleaves the mRNA of secretory μ chains, which explains the reduction in secretory μ mRNA and its synthesis in XBP-1 KO plasma cells. In accordance, the IgM response is partially restored in XBP-1/IRE1 double KO mice relative to XBP-1 KO mice. Interestingly, the IgG1 response is reduced to a similar level in XBP-1 KO, IRE1 KO, and their double knockout animals. Our data demonstrate a specific contribution by RIDD in curtailing immunoglobulin synthesis and secretion.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  ER stress; IRE1; RIDD; UPR; XBP-1; plasma cells

Mesh:

Substances:

Year:  2013        PMID: 24242955     DOI: 10.1002/eji.201343953

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  36 in total

1.  Secretory IgM Exacerbates Tumor Progression by Inducing Accumulations of MDSCs in Mice.

Authors:  Chih-Hang Tang; Shiun Chang; Ayumi Hashimoto; Yi-Ju Chen; Chang Won Kang; Anthony R Mato; Juan R Del Valle; Dmitry I Gabrilovich; Chih-Chi Hu
Journal:  Cancer Immunol Res       Date:  2018-04-12       Impact factor: 11.151

Review 2.  Here, There, and Anywhere? Arguments for and against the Physical Plasma Cell Survival Niche.

Authors:  Joel R Wilmore; David Allman
Journal:  J Immunol       Date:  2017-08-01       Impact factor: 5.422

Review 3.  The generation of antibody-secreting plasma cells.

Authors:  Stephen L Nutt; Philip D Hodgkin; David M Tarlinton; Lynn M Corcoran
Journal:  Nat Rev Immunol       Date:  2015-02-20       Impact factor: 53.106

Review 4.  Endoplasmic reticulum stress and the unfolded protein responses in retinal degeneration.

Authors:  Sarah X Zhang; Emily Sanders; Steven J Fliesler; Joshua J Wang
Journal:  Exp Eye Res       Date:  2014-05-02       Impact factor: 3.467

Review 5.  Emerging functions of the unfolded protein response in immunity.

Authors:  Sophie Janssens; Bali Pulendran; Bart N Lambrecht
Journal:  Nat Immunol       Date:  2014-10       Impact factor: 25.606

Review 6.  The unfolded protein response in skeletal development and homeostasis.

Authors:  Keisuke Horiuchi; Takahide Tohmonda; Hideo Morioka
Journal:  Cell Mol Life Sci       Date:  2016-03-22       Impact factor: 9.261

Review 7.  Metabolic Control of Plasma Cell Differentiation- What We Know and What We Don't Know.

Authors:  Michael Aronov; Boaz Tirosh
Journal:  J Clin Immunol       Date:  2016-02-24       Impact factor: 8.317

Review 8.  Endoplasmic reticulum proteostasis: a key checkpoint in cancer.

Authors:  Scott A Oakes
Journal:  Am J Physiol Cell Physiol       Date:  2016-11-16       Impact factor: 4.249

Review 9.  ER-associated degradation in health and disease - from substrate to organism.

Authors:  Asmita Bhattacharya; Ling Qi
Journal:  J Cell Sci       Date:  2019-12-02       Impact factor: 5.285

10.  mTOR activation promotes plasma cell differentiation and bypasses XBP-1 for immunoglobulin secretion.

Authors:  Sandrine Benhamron; Shakti P Pattanayak; Michael Berger; Boaz Tirosh
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.